Acute vagotomy does not augment the systemic inflammatory response in patients with peptic ulcer disease

American Surgeon

Volumn 70, Issue 4, 2004, Pages 342-346

  Heider, T Ryan ^a   Koruda, Mark J ^a   Farrell, Timothy M ^a   Behrns, Kevin E ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE DISEASE; ADULT; ARTICLE; COHORT ANALYSIS; COMPARATIVE STUDY; FEMALE; HOSPITALIZATION; HUMAN; INCIDENCE; INFLAMMATION; MALE; METHODOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; PEPTIC ULCER; POSTOPERATIVE COMPLICATION; REFERENCE VALUE; RETROSPECTIVE STUDY; RISK ASSESSMENT; SEPTIC SHOCK; TREATMENT OUTCOME; TRUNCUS VAGOTOMY;

ACUTE DISEASE; ADULT; COHORT STUDIES; FEMALE; HUMANS; INCIDENCE; INFLAMMATION; MALE; MIDDLE AGED; PEPTIC ULCER; POSTOPERATIVE COMPLICATIONS; REFERENCE VALUES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SHOCK, SEPTIC; TREATMENT OUTCOME; VAGOTOMY, TRUNCAL;

EID: 2342643408     PISSN: 00031348     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Gaykema RPA, Dukstra I, Tilders FJH. Subdiaphragmatic vagotomy suppresses endotoxin-induced activation of hypothalamic corticotropin-releasing hormone neurons and ACTH secretion. Endocrinology 1995;136:4717-4720
2. Fleshner M, Goehler LE, Scwartz BA, et al. Thermogenic and corticosterone responses to intravenous cytokines (IL-1beta and TNF-alpha) are attenuated by subdiaphragmatic vagotomy. J Neuroimmunol 1998;86(2):134-141 (Pubitemid 28305354)
3. Watkins LR, Goehler LE, Relton JK, et al. Blockade of interleukin-1 induced hyperthermia by subdiaphragmatic vagotomy: Evidence for vagal mediation of immune-brain communication. Neurosci Lett 1995;183:27-31.
4. Romanovsky AA, Simons CT, Szekely M, et al. The vagus nerve in the thermoregulatory response to systemic inflammation. Am J Physiol 1997;273:R407-13. (Pubitemid 27345599)
5. Borovikova LV, Ivanova S, Zhang M, et al. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 2000;405(6785):458-462 (Pubitemid 30367422)
6. Niijima A. The afferent discharges from sensors for interleukin Iβ in the hepatoportal system in the anaesthetized rat (Abstract) J Physiol 1992;446:236P.
7. Goehler LE, Relton JK, Dripps D, et al. Vagal paraganglia bind biotinylated interleukin-1 receptor antagonist (IL-1ra) in the rat: a possible mechanism for immune-to-brain communication. Brain Res Bull 1997;43:357-364 (Pubitemid 27282130)
8. Ericsson A, Kovacs KJ, Sawchenko PE. A functional anatomical analysis of central pathways subserving the effects of interleukin-1 on stress-related neuroendocrine neurons. J Neurosci 1994;14:897-913. (Pubitemid 24043940)
9. Li HY, Ericsson A, Sawchenko PE. Distinct mechanisms underlie activation of hypothalamic neurosecretory neurons and their medullary catecholaminergic afferents in categorically different stress paradigms. Proc Natl Acad Sci USA 1996;93:2359-2364 (Pubitemid 26104355)
10. Bernik TR, Friedman SG, Ochani M, et al. Pharmacological stimulation of the cholinergic anti-inflammatory pathway. J Exp Med 2002;195:781-788 (Pubitemid 34259722)
11. Wang H, Yu M, Ochani M, et al. Nicotinic acetylcholine receptor alpha-7 is an essential regulator of inflammation. Nature 2003;421:384-388 (Pubitemid 36157937)
12. Tracey KJ. The inflammatory reflex. Nature 2002;420:853-859
13. Fletcher DR. Peptic disease: can we afford current management? Aust N Z J Surgery 1997;67(2-3):75-80.
14. Ishikawa M, Ogata S, Harada M, et al. Changes in surgical strategies for peptic ulcers before and after the introduction of H2-receptor antagonists and endoscopic hemostasis. Surg Today 1995;25:318-323
15. Paimela H, Tuompo PK, Parakyl T, et al. Peptic ulcer surgery during the H2-receptor antagonist era: A population-based epidemiological study of ulcer surgery in Helsinki from 1972 to 1987. Br J Surg 1991;78:28-31.
16. Paimela H, Joutsi T, Kiviluoto T, et al. Recent trends in mortality from peptic ulcer disease in Finland. Dig Dis Sci 1995;40:631-635
17. Svanes C, Salvesen H, Espehaug B, et al. A multifactorial analysis of factors related to lethality after treatment of perforated gastroduodenal ulcer. Ann Surg 1989;299:418-423 (Pubitemid 19106271)
18. Gunshefski L, Flancbaum L, Brolin RE, et al. Changing patterns in perforated peptic ulcer disease. Am Surg 1990;56:270-274 (Pubitemid 20144065)
19. Boey J, Wong J, Ong GB. A prospective study of operative risk factors in perforated duodenal ulcers. Ann Surg 1982;195:256-259 (Pubitemid 12185012)
20. Bennett KG, Cannon JP, Organ CO. Is duodenal perforation best treated with vagotomy and pyloroplasty. Am J Surg 1985;150:743-747
21. Ceneviva R, de Castro O Jr, Castelfranchi PL, et al. Simple suture with or without proximal gastric vagotomy for perforated duodenal ulcer. Br J Surg 1986;73:427-430 (Pubitemid 16092837)
22. Heuman R, Larsson J, Norrby S. Perforated duodenal ulcer: Long-term results following simple closure. Acta Chir Scand 1983;149:77-81. (Pubitemid 13184697)
23. Donovan AJ, Vinson TL, Maulsby GO, et al. Selective treatment of duodenal ulcer with perforation. Ann Surg 1979;189:627-636 (Pubitemid 9187514)
24. Duthie HL, Moore KTH, Bardsley D, et al. Surgical treatment of gastric ulcers - controlled comparison of Billroth I gastrectomy and vagotomy and pyloroplasty. Br J Surg 1970;57:784-787
25. Robles R, Parrilla P, Lujan JA, et al. Long-term follow-up of bilateral truncal vagotomy and pyloroplasty for perforated duodenal ulcer. Br J Surg 1995;82:665.
26. Koruth NM, Dua KS, Brunt PW, et al. Comparison of highly selective vagotomy with truncal vagotomy and pyloroplasty: results at 8-15 years. Br J Surg 1990;77:70-72
27. Rizoli SB, Neto AC, Diorio AC, et al. Risk of complication in perforated duodenal ulcer operations according to the surgical technique employed. Am Surg 1993;59:312-314
28. Mannick JA, Rodrick ML, Lederer JA. The immunologic response to injury. J Am Coll Surg 2001;193:237-244